ArticleFrontiers in oncology2025
Development and validation of a deep learning algorithm for discriminating glioma recurrence from radiation necrosis on MRI.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Convolutional neural networks: applications, challenges and future prospects in brain tumor research.Frontiers in neurologyReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Accurate differentiation between glioma recurrence and radiation necrosis is critical for the management of patients suspected of glioma recurrence following radiation therapy. This study aims to develop a deep learning-based methodology for automated discrimination between glioma recurrence and radiation necrosis using routine magnetic resonance imaging (MRI) scans. Method: We retrospectively investigated 234 patients who underwent radiotherapy after glioma resection and presented with suspected recurrent lesions during follow-up MRI examinations. Routine 3D-MRI scans, including T1-weighted, T2-weighted, and contrast-enhanced T1 (T1ce) sequences, were acquired for each patient. Among the analyzed cases, 192 (82.1%) were pathologically confirmed as glioma recurrence, while 42 (17.9%) were diagnosed as radiation necrosis. Various Convolutional Neural Network (CNN) models were employed to learn radiological features indicative of glioma recurrence and radiation necrosis from the MRI scans. Performance evaluation metrics, such as sensitivity, specificity, accuracy, and area under the curve (AUC), were used to assess the models' performance. Result: Among the evaluated CNN models, ResNet10 demonstrated the highest sensitivity (0.78), specificity (0.94), accuracy (0.91), and an AUC value of 0.83. Additionally, the MresNet model achieved the highest specificity (0.980) but exhibited a relatively lower sensitivity (0.56). Another evaluated CNN model, Vgg16, showed a sensitivity of 0.56, specificity of 0.94, accuracy of 0.88, and an AUC value of 0.70. Conclusion: The proposed ResNet10 CNN model demonstrates promising performance on routine MRI scans, rendering it highly applicable in clinical settings. These findings contribute to enhancing the diagnostic accuracy for distinguishing between glioma recurrence and radiation necrosis using routine MRI.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.